Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 80, Issue 5, 2009, Pages 498-505

  Pender, M P ^a,b   Csurhes, P A ^a   Lenarczyk, A ^a   Pfluger, C M M ^a   Burrows, S R ^c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN G ANTIBODY; VIRUS CAPSID ANTIGEN; HLA ANTIGEN; IMMUNOGLOBULIN G; VIRUS ANTIBODY;

ADULT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL KILLING; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; EPSTEIN BARR VIRUS; FEMALE; HLA MATCHING; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOMODULATION; LYMPHOBLASTOID CELL LINE; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTOTOXICITY; MALE; MOLECULAR CLONING; MULTIPLE SCLEROSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; SEROLOGY; VIRUS INFECTION; BIOSYNTHESIS; CELL LINE; CELL SURVIVAL; FLOW CYTOMETRY; IMMUNOLOGY; MONOCYTE; T LYMPHOCYTE; VIROLOGY;

ADULT; ANTIBODIES, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CELL SURVIVAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; FLOW CYTOMETRY; HERPESVIRUS 4, HUMAN; HLA ANTIGENS; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; MALE; MONOCYTES; MULTIPLE SCLEROSIS; T-LYMPHOCYTES;

EID: 65449166882     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2008.161018     Document Type: Article

References (34)

1. Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 2005;23:683-747. (Pubitemid 40563183)
2. Pender MP, Greer JM. Immunology of multiple sclerosis. Curr Allergy Asthma Rep 2007;7:285-92. (Pubitemid 46958746)
3. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: The role of infection. Ann Neurol 2007;61:288-99. (Pubitemid 46676728)
4. Pohl D, Krone B, Rostasy K, et al. High seroprevalence of Epstein-Barr virus in children with multiple sclerosis. Neurology 2006;67:2063-5.
5. Thorley-Lawson DA. Epstein-Barr virus: exploiting the immune system. Nat Rev Immunol 2001;1:75-82. (Pubitemid 33741978)
6. Pender MP. Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases. Trends Immunol 2003;24:584-8. (Pubitemid 37338526)
7. Serafini B, Rosicarelli B, Franciotta D, et al. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 2007;204:2899-912. (Pubitemid 350179559)
8. Craig JC, Haire M, Merrett JD. T-cell-mediated suppression of Epstein-Barr virusinduced B lymphocyte activation in multiple sclerosis. Clin Immunol Immunopathol 1988;48:253-60. (Pubitemid 18201974)
9. Höllsberg P, Hansen HJ, Haahr S. Altered CD8+ T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis. Clin Exp Immunol 2003;132:137-43. (Pubitemid 36418916)
10. Gronen F, Ruprecht K, Weissbrich B, et al. Frequency analysis of HLA-B7-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes in patients with multiple sclerosis and healthy controls. J Neuroimmunol 2006;180:185-92.
11. Jilek S, Schluep M, Meylan P, et al. Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis. Brain 2008;131:1712-21.
12. Lünemann JD, Edwards N, Muraro PA, et al. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis. Brain 2006;129:1493-506. (Pubitemid 43999382)
13. Pudney VA, Leese AM, Rickinson AB, et al. CD8+ immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells. J Exp Med 2005;201:349-60. (Pubitemid 40229410)
14. Tynan FE, Elhassen D, Purcell AW, et al. The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation. J Exp Med 2005;202:1249-60. (Pubitemid 41586955)
15. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 Revisions to the "McDonald Criteria". Ann Neurol 2005;58:840-6. (Pubitemid 41746873)
16. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52. (Pubitemid 14237132)
17. Roxburgh RHSR, Seaman SR, Masterman T, et al. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 2005;64:1144-51. (Pubitemid 40490510)
18. Burrows SR, Silins SL, Moss DJ, et al. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen. J Exp Med 1995;182:1703-15.
19. Shi Y, Smith KD, Kurilla MG, et al. Cytotoxic CD8+ T cells recognize EBV antigen but poorly kill autologous EBV-infected B lymphoblasts. Immunodominance is elicited by a peptide epitope that is presented at low levels in vitro. J Immunol 1997;159:1844-52. (Pubitemid 127484172)
20. Yang J, Lemas VM, Flinn IW, et al. Application of the ELISPOT assay to the characterization of CD8+ responses to Epstein-Barr virus antigens. Blood 2000;95:241-8. (Pubitemid 30017248)
21. Harbo HF, Lie BA, Sawcer S, et al. Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens 2004;63:237-47. (Pubitemid 38297258)
22. Hill AB, Lee SP, Haurum JS, et al. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised. J Exp Med 1995;181:2221-8.
23. Steven NM, Leese AM, Annels NE, et al. Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memory. J Exp Med 1996;184:1801-13. (Pubitemid 26404471)
24. Greer JM, Csurhes PA, Muller DM, et al. Correlation of blood T cell and antibody reactivity to myelin proteins with HLA type and lesion localization in multiple sclerosis. J Immunol 2008;180:6402-10.
25. Cepok S, Zhou D, Srivastava R, et al. Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J Clin Invest 2005;115:1352-60. (Pubitemid 40629055)
26. Larsen PD, Bloomer LC, Bray PF. Epstein-Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis. Neurology 1985;35:435-8. (Pubitemid 15100694)
27. Sumaya CV, Myers LW, Ellison GW, et al. Increased prevalence and titer of Epstein-Barr virus antibodies in patients with multiple sclerosis. Ann Neurol 1985;17:371-7. (Pubitemid 15079065)
28. Ascherio A, Munger KL, Lennette ET, et al. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 2001;286:3083-8. (Pubitemid 34016522)
29. Sundström P, Juto P, Wadell G, et al. An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study. Neurology 2004;62:2277-82. (Pubitemid 38787787)
30. Levin LI, Munger KL, Rubertone MV, et al. Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA 2005;293:2496-500. (Pubitemid 40705731)
31. Klenerman P, Hill A. T cells and viral persistence: lessons from diverse infections. Nat Immunol 2005;6:873-9. (Pubitemid 43090441)
32. Goldberger AL. Non-linear dynamics for clinicians: chaos theory, fractals, and complexity at the bedside. Lancet 1996;347:1312-14. (Pubitemid 26137801)
33. Goldberger AL, Giles F. Filley Lecture. Complex systems. Proc Am Thorac Soc 2006;3:467-72.
34. Palendira U, Chinn R, Raza W, et al. Selective accumulation of virus-specific CD8+ T cells with unique homing phenotype within the human bone marrow. Blood 2008;112:3293-302.